Table 4 Demographic data of group D (7–14 years, n = 160)
From: The efficacy and safety of mivacurium in pediatric patients
Subgroups | n | Percentage in group A (%) | Sex (M/F) | Body weight (kg) | Induction dose (mg/kg) | Injecting time (s) |
|---|---|---|---|---|---|---|
Group 13 | 40 | 25 | 26/14 | 31.1 ± 11.3 | 0.20 | 20 |
Group 14 | 40 | 25 | 27/13 | 34.6 ± 17.2 | 0.20 | 40 |
Group 15 | 40 | 25 | 30/10 | 33.7 ± 11.8 | 0.25 | 20 |
Group 16 | 40 | 25 | 27/13 | 32.2 ± 13.1 | 0.25 | 40 |